Akoya Biosciences Inc expected to post a loss of 39  cents a share - Earnings Preview

Akoya Biosciences

04/05/2022 03:05

* Akoya Biosciences Inc  AKYA.OQ   AKYA.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 5. 
    * The Marlborough Massachusetts-based  company is expected
to
report  a 22.3% increase in revenue to $14.933 million from
$12.21 million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Akoya Biosciences
Inc is
for a loss of 39 cents per share. For the same quarter last
year, the company reported a loss of $3.54 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Akoya
Biosciences
Inc is $19​, above​ its last closing price of $10.80. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.29       -0.31      -0.47     Missed  -51.6
 Sep. 30 2021  -0.26       -0.26      -0.31     Missed  -17
 Jun. 30 2021  -0.23       -0.23      -0.20     Beat    13​
 Mar. 31 2021  -0.17       -0.17      -3.54     Missed  -2,013
                                                        .4
 ​​                                                     
                                                        ​
 This summary was machine generated May 4 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated